DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

BMO Capital Initiates Coverage On Seattle Genetics with Outperform Rating, Announces $139 Price Target

BMO Capital analyst George Farmer initiates coverage on Seattle Genetics (NASDAQ:SGEN) with a Outperform rating and a $139 price target.

Benzinga · 01/28/2020 11:54

BMO Capital analyst George Farmer initiates coverage on Seattle Genetics (NASDAQ:SGEN) with a Outperform rating and a $139 price target.